Results From a First-in-Human Study of BNZ-1, a Selective Multicytokine Inhibitor Targeting Members of the Common Gamma (γc) Family of Cytokines. [electronic resource]
Producer: 20210211Description: 264-273 p. digitalISSN:- 1552-4604
- Adult
- B-Lymphocytes -- drug effects
- Female
- Healthy Volunteers
- Humans
- Infusions, Intravenous
- Interleukin Receptor Common gamma Subunit -- metabolism
- Interleukin-15 -- antagonists & inhibitors
- Interleukin-2 -- antagonists & inhibitors
- Interleukin-9 -- antagonists & inhibitors
- Killer Cells, Natural -- drug effects
- Male
- Peptides -- administration & dosage
- T-Lymphocytes -- drug effects
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.